Page last updated: 2024-10-30

metformin and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

metformin has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin is the most common anti-diabetic drug and a promising therapy for disorders beyond diabetes, including Rett syndrome (RTT), a rare neurologic disease characterized by severe intellectual disability."8.31Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome. ( Cosentino, L; De Filippis, B; Di Crescenzo, L; Di Domenico, F; Lanzillotta, C; Perluigi, M; Pietraforte, D; Prestia, F; Quattrini, MC; Urbinati, C; Vacca, RA; Valenti, D, 2023)
"Metformin is the most common anti-diabetic drug and a promising therapy for disorders beyond diabetes, including Rett syndrome (RTT), a rare neurologic disease characterized by severe intellectual disability."4.31Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome. ( Cosentino, L; De Filippis, B; Di Crescenzo, L; Di Domenico, F; Lanzillotta, C; Perluigi, M; Pietraforte, D; Prestia, F; Quattrini, MC; Urbinati, C; Vacca, RA; Valenti, D, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Urbinati, C3
Lanzillotta, C3
Cosentino, L3
Valenti, D3
Quattrini, MC3
Di Crescenzo, L3
Prestia, F3
Pietraforte, D3
Perluigi, M3
Di Domenico, F3
Vacca, RA3
De Filippis, B3

Other Studies

1 other study available for metformin and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.
    Neuropharmacology, 2023, 02-15, Volume: 224

    Topics: Animals; Brain; Cognition; Diabetes Mellitus; Disease Models, Animal; Female; Metformin; Mice; Rett

2023
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.
    Neuropharmacology, 2023, 02-15, Volume: 224

    Topics: Animals; Brain; Cognition; Diabetes Mellitus; Disease Models, Animal; Female; Metformin; Mice; Rett

2023
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.
    Neuropharmacology, 2023, 02-15, Volume: 224

    Topics: Animals; Brain; Cognition; Diabetes Mellitus; Disease Models, Animal; Female; Metformin; Mice; Rett

2023
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome.
    Neuropharmacology, 2023, 02-15, Volume: 224

    Topics: Animals; Brain; Cognition; Diabetes Mellitus; Disease Models, Animal; Female; Metformin; Mice; Rett

2023